Life Sciences
Alife also added Deena Shakir, a partner at Lux Capital, to its board of directors.
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.
Interested researchers must submit a letter of intent describing their research and how they will use Fitbit’s products and services in it.
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
According to FDA documents, the test is intended to help stop the spread of COVID-19 among Amazon employees.
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
The pilot study in north-east England will pioneer a personalised medicine approach.
The pair talk about the shift from traditional clinical trials based on drug research to digital innovations.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
Symmetric Health Solutions CEO Rich Kucera and Northern Light's Matt Marston discuss how COVID-19 has affected the supply chain as well as Northern Light's successful vaccine rollout.